Somalogic Inc Up 19.12% To $2.43 After Earnings Beat

Somalogic Inc (SLGC) said after close Wednesday that it lost $0.12 per share in quarter three 2023.

On the revenue line, the company reported $22 million, beating estimates by $1.6 million.

In the same quarter a year ago, the company lost $0.18 per share on revenue of $41.7 million.

The stock is up 19.12% to $2.43 after the report.

Somalogic Inc's revenues declined at a faster pace than earnings.

Wall Street Analysts had an average rating of Buy on the stock prior to the report.

Trading in the five days leading up to the report earned Somalogic Inc a Bearish Sentiment Rank from InvestorsObserver.

Somalogic Inc has performed poorly during the past few months, garnering a low Long-Term Technical Rank by InvestorsObserver of 10, putting Somalogic Inc in the bottom 25% of stocks. The firm was recently trading at a 52-week low of $1.73 on October 13, 2023 and set a 52-week high on February 2, 2023 at $3.79.

SomaLogic Inc delivers precise and actionable health-management information that helps individuals to optimize their personal health and wellness throughout their lives. This information, to be provided through a global network of partners and users, is derived from its personalized measurement of changes in an individual's proteins over time.